BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 33998548)

  • 21. Effects of 5-HT1A receptor stimulation on D1 receptor agonist-induced striatonigral activity and dyskinesia in hemiparkinsonian rats.
    Dupre KB; Ostock CY; George JA; Eskow Jaunarajs KL; Hueston CM; Bishop C
    ACS Chem Neurosci; 2013 May; 4(5):747-60. PubMed ID: 23496922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of coincident 5-HT1A receptor stimulation and NMDA receptor antagonism on L-DOPA-induced dyskinesia and rotational behaviors in the hemi-parkinsonian rat.
    Dupre KB; Eskow KL; Steiniger A; Klioueva A; Negron GE; Lormand L; Park JY; Bishop C
    Psychopharmacology (Berl); 2008 Jul; 199(1):99-108. PubMed ID: 18545986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contribution of brain serotonin subtype 1B receptors in levodopa-induced motor complications.
    Morin N; Morissette M; Grégoire L; Rajput A; Rajput AH; Di Paolo T
    Neuropharmacology; 2015 Dec; 99():356-68. PubMed ID: 26254863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of Vilazodone, YL-0919 and Vortioxetine in hemiparkinsonian rats.
    Smith S; Sergio J; Coyle M; Elder K; Centner A; Cohen S; Terry M; Lipari N; Glinski J; Wheelis E; Budrow C; Bishop C
    Psychopharmacology (Berl); 2022 Jul; 239(7):2119-2132. PubMed ID: 35275226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the primary motor cortex in L-Dopa-induced dyskinesia and its modulation by 5-HT1A receptor stimulation.
    Ostock CY; Dupre KB; Jaunarajs KL; Walters H; George J; Krolewski D; Walker PD; Bishop C
    Neuropharmacology; 2011 Sep; 61(4):753-60. PubMed ID: 21635907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Local modulation of striatal glutamate efflux by serotonin 1A receptor stimulation in dyskinetic, hemiparkinsonian rats.
    Dupre KB; Ostock CY; Eskow Jaunarajs KL; Button T; Savage LM; Wolf W; Bishop C
    Exp Neurol; 2011 Jun; 229(2):288-99. PubMed ID: 21352823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Striatal 5-HT1A receptor stimulation reduces D1 receptor-induced dyskinesia and improves movement in the hemiparkinsonian rat.
    Dupre KB; Eskow KL; Barnum CJ; Bishop C
    Neuropharmacology; 2008 Dec; 55(8):1321-8. PubMed ID: 18824001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Side effect profile of 5-HT treatments for Parkinson's disease and L-DOPA-induced dyskinesia in rats.
    Lindenbach D; Palumbo N; Ostock CY; Vilceus N; Conti MM; Bishop C
    Br J Pharmacol; 2015 Jan; 172(1):119-30. PubMed ID: 25175895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5-Hydroxy-tryptophan for the treatment of L-DOPA-induced dyskinesia in the rat Parkinson's disease model.
    Tronci E; Lisci C; Stancampiano R; Fidalgo C; Collu M; Devoto P; Carta M
    Neurobiol Dis; 2013 Dec; 60():108-14. PubMed ID: 24004632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulating mGluR5 and 5-HT1A/1B receptors to treat l-DOPA-induced dyskinesia: effects of combined treatment and possible mechanisms of action.
    Iderberg H; Rylander D; Bimpisidis Z; Cenci MA
    Exp Neurol; 2013 Dec; 250():116-24. PubMed ID: 24029003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serotonin neuron-dependent and -independent reduction of dyskinesia by 5-HT1A and 5-HT1B receptor agonists in the rat Parkinson model.
    Muñoz A; Carlsson T; Tronci E; Kirik D; Björklund A; Carta M
    Exp Neurol; 2009 Sep; 219(1):298-307. PubMed ID: 19500572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of piclozotan (SUN N4057), a partial serotonin 1A receptor agonist, on motor complications induced by repeated administration of levodopa in parkinsonian rats.
    Tani Y; Ogata A; Koyama M; Inoue T
    Eur J Pharmacol; 2010 Dec; 649(1-3):218-23. PubMed ID: 20858480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The anti-dyskinetic effect of dopamine receptor blockade is enhanced in parkinsonian rats following dopamine neuron transplantation.
    Shin E; Lisci C; Tronci E; Fidalgo C; Stancampiano R; Björklund A; Carta M
    Neurobiol Dis; 2014 Feb; 62():233-40. PubMed ID: 24135006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The sigma-1 antagonist BMY-14802 inhibits L-DOPA-induced abnormal involuntary movements by a WAY-100635-sensitive mechanism.
    Paquette MA; Foley K; Brudney EG; Meshul CK; Johnson SW; Berger SP
    Psychopharmacology (Berl); 2009 Jul; 204(4):743-54. PubMed ID: 19283364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multimodal imaging study of the 5-HT
    Chaib S; Vidal B; Bouillot C; Depoortere R; Newman-Tancredi A; Zimmer L; Levigoureux E
    Neuroimage Clin; 2023; 39():103497. PubMed ID: 37632990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of correlation between dyskinesia and pallidal serotonin transporter expression-induced by L-Dopa and Pramipexole in hemiparkinsonian rats.
    Marin C; Bonastre M; Fuentes M; Mullol J
    Pharmacol Biochem Behav; 2020 Oct; 197():173012. PubMed ID: 32750392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. (6aR)-11-amino-N-propyl-noraporphine, a new dopamine D2 and serotonin 5-HT1A dual agonist, elicits potent antiparkinsonian action and attenuates levodopa-induced dyskinesia in a 6-OHDA-lesioned rat model of Parkinson's disease.
    Zhao R; Lu W; Fang X; Guo L; Yang Z; Ye N; Zhao J; Liu Z; Jia J; Zheng L; Zhao B; Zhang A; Zhen X
    Pharmacol Biochem Behav; 2014 Sep; 124():204-10. PubMed ID: 24955866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of L-dopa priming on cortical high beta and high gamma oscillatory activity in a rodent model of Parkinson's disease.
    Dupre KB; Cruz AV; McCoy AJ; Delaville C; Gerber CM; Eyring KW; Walters JR
    Neurobiol Dis; 2016 Feb; 86():1-15. PubMed ID: 26586558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease.
    Frau R; Savoia P; Fanni S; Fiorentini C; Fidalgo C; Tronci E; Stancampiano R; Meloni M; Cannas A; Marrosu F; Bortolato M; Devoto P; Missale C; Carta M
    Exp Neurol; 2017 May; 291():1-7. PubMed ID: 28131725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An autoradiographic study on the pathogenesis of levodopa-induced dyskinesia: regulation of dopamine transporter by levodopa in a rat model of Parkinson's disease.
    Cai XY; Kong XM; Fang Q; Ning P; Xu YJ; Zhang B; Xue SR
    Neurodegener Dis; 2012; 9(1):11-7. PubMed ID: 21876323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.